National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
J Mater Chem B. 2019 May 7;7(17):2845-2854. doi: 10.1039/c9tb00211a. Epub 2019 Apr 1.
Development of an in situ injectable hydrogel with controlled-release of bioactive molecules is an effective strategy to maintain chondrocyte phenotype and promote cartilage formation for clinical applications. In this study, we developed an injectable thiolated icariin functionalized hyaluronic acid/collagen hydrogel (HIC) under physiological conditions. In order to covalently introduce icariin (Ica) into an injectable hydrogel and increase its loading, thiolated icariin (Ica-SH) was successfully synthesized. Ica-SH could not only decrease the cytotoxicity of Ica, but also increase the Ica loading in hydrogels. Compared to hyaluronic acid/collagen hydrogels, HICs facilitated chondrocyte proliferation, maintained chondrocyte phenotype and promoted the secretion of the cartilage extracellular matrix. Overall, this study suggests that HIC has great potential to be developed as an effective and less invasive candidate for clinical application in articular cartilage repair.
研发具有生物活性分子控释功能的原位可注射水凝胶是一种保持软骨细胞表型和促进软骨形成的有效策略,可用于临床应用。在本研究中,我们在生理条件下开发了一种可注射的巯基化淫羊藿苷功能化透明质酸/胶原水凝胶(HIC)。为了将淫羊藿苷(Ica)共价引入可注射水凝胶并增加其载药量,成功合成了巯基化淫羊藿苷(Ica-SH)。Ica-SH 不仅可以降低 Ica 的细胞毒性,还可以增加水凝胶中的 Ica 载药量。与透明质酸/胶原水凝胶相比,HIC 促进了软骨细胞的增殖,保持了软骨细胞的表型,并促进了软骨细胞外基质的分泌。总的来说,这项研究表明,HIC 具有作为一种有效且微创的候选物在关节软骨修复中的临床应用的巨大潜力。